Source:http://linkedlifedata.com/resource/pubmed/id/17635153
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 4
|
pubmed:dateCreated |
2007-7-19
|
pubmed:abstractText |
The therapeutic application of siRNA (short interfering RNA) shows promise as an alternative approach to small-molecule inhibitors for the treatment of human disease. However, the major obstacle to its use has been the difficulty in delivering these large anionic molecules in vivo. A potential approach to solving this problem is the chemical conjugation of siRNA to the cationic CPPs (cell-penetrating peptides), Tat-(48-60) (transactivator of transcription) and penetratin, which have been shown previously to mediate protein and peptide delivery in a host of animal models. In this transaction, we review recent studies on the utility of siRNA for the investigation of protein function in the airways/lung. We show that, despite previous studies showing the utility of cationic CPPs in vitro, conjugation of siRNA to Tat-(48-60) and penetratin failed to increase residual siRNA-mediated knockdown of p38 MAPK (mitogen-activated protein kinase) (MAPK14) mRNA in mouse lung in vivo. Significantly, we will also discuss potential non-specific actions and the induction of immunological responses by CPPs and their conjugates and how this might limit their application for siRNA-mediated delivery in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0300-5127
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
807-10
|
pubmed:meshHeading |
pubmed-meshheading:17635153-Animals,
pubmed-meshheading:17635153-Drug Delivery Systems,
pubmed-meshheading:17635153-Humans,
pubmed-meshheading:17635153-Lung,
pubmed-meshheading:17635153-Peptides,
pubmed-meshheading:17635153-Protein Sorting Signals,
pubmed-meshheading:17635153-Protein Transport,
pubmed-meshheading:17635153-RNA, Small Interfering
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cell-penetrating-peptide-mediated siRNA lung delivery.
|
pubmed:affiliation |
Biopharmaceutics Research Group, Airways Disease, National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|